On July 27, Intuitive Surgical rose 3.2% in regular trading, trading at $352.79/share, with turnover of $182 million. The rebound came as Rothschild & Co Redburn lowered its price target from $615 to $540 but maintained a Buy rating, implying approximately 53% upside from the current price level, providing support for the oversold stock.

Additionally, the company announced a collaboration with Deion \"Coach Prime\" Sanders to raise patient awareness of surgical options, signaling an active commercial marketing push. The partnership leverages Sanders' public influence to promote understanding of modern surgical choices.

The stock had previously plunged over 11% following its Q2 earnings report on July 17. While adjusted EPS of $2.80 beat consensus by 12% and revenue of $2.89 billion also exceeded expectations, management maintained its full-year da Vinci procedure growth outlook of 13.5% to 15.5% without raising guidance, disappointing investors hoping for an upward revision. Multiple Wall Street firms have since cut price targets, though the majority maintain overweight or outperform ratings, with a consensus mean target near $492.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)